3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
10
Spondylitis, Ankylosing
2
Spondylarthritis
1
Psoriasis
1
Joint Diseases
1
Inflammatory Bowel Diseases
1
Crohn Disease
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis
1
Interventions
secukinumab
1
Methotrexate
1
Folic Acid
1
Etanercept
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Psoriasis
×
Adalimumab
×
Clear all
NCT00932113
2017-08-31
MOA
Tufts Medical Center
Phase 4
Completed
33 enrolled
11 charts